Affiliation: University of Zambia
- Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in ZambiaAlwyn Mwinga
AIDS 16:806-8. 2002
- Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trialAlwyn Mwinga
University of Zambia University College London Tuberculosis HIV Research and Training Project, Lusaka, Zambia
Lancet 360:1050-5. 2002..Mortality rates of HIV-infected patients treated for tuberculosis remain high. This study aimed to assess the effect on mortality of immunotherapy with single-dose SRL172 added to standard antituberculosis chemotherapy in such patients...
- Challenges and hope for the diagnosis of tuberculosis in infants and young childrenAlwyn Mwinga
Global AIDS Program, Centers for Disease Control and Prevention, PO Box 31617, Lusaka, Zambia
Lancet 365:97-8. 2005
- Drug-resistant tuberculosis in AfricaA Mwinga
Department of Medicine, University of Zambia, Lusaka
Ann N Y Acad Sci 953:106-12. 2001..Establishment of programs to ensure prompt diagnosis of TB and adequate treatment with supervision should be undertaken by national governments with cooperating partners...
- Prospects for new tuberculosis treatment in AfricaA Mwinga
University Teaching Hospital, Lusaka, Zambia
Trop Med Int Health 9:827-32. 2004....
- Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year reviewN Kapata
Ministry of Health, Lusaka, Zambia
Trop Med Int Health 17:760-6. 2012..To review the activities, progress, achievements and challenges of the Zambia Ministry of Health tuberculosis (TB)/HIV collaborative activities over the past decade...
- Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, ZambiaBenjamin H Chi
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Int J Epidemiol 38:746-56. 2009..In resource-constrained settings, however, there are few validated measures. We examined the correlation between clinical outcomes and the medication possession ratio (MPR), a pharmacy-based measure of adherence...
- Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cellsAnn L N Chapman
Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
AIDS 16:2285-93. 2002..We investigated whether T cells specific for these antigens could serve as accurate markers of M. tuberculosis infection in an area of high tuberculosis and HIV prevalence...
- Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomesJeffrey S A Stringer
Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, USA
JAMA 296:782-93. 2006..The Zambian Ministry of Health has scaled-up human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) care and treatment services at primary care clinics in Lusaka, using predominately nonphysician clinicians...
- Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trialAndrew J Nunn
Medical Research Council Clinical Trials Unit, London NW1 2DA
BMJ 337:a257. 2008..To assess the impact of prophylactic oral co-trimoxazole in reducing mortality in HIV positive Zambian adults being treated for pulmonary tuberculosis...
- Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, ZambiaLloyd B Mulenga
Centre for Infectious Disease Research, Zambia
AIDS 22:1821-7. 2008..To examine the association between baseline renal insufficiency and mortality among adults initiating antiretroviral therapy (ART) in an urban African setting...